• No results found

University of Groningen A lifetime with Phenylketonuria Jahja, Rianne

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen A lifetime with Phenylketonuria Jahja, Rianne"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

A lifetime with Phenylketonuria

Jahja, Rianne

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2017

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Jahja, R. (2017). A lifetime with Phenylketonuria: Towards a better understanding of therapeutic targets. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Stellingen

behorend bij het proefschrift

A lifetime with Phenylketonuria

Towards a better understanding of therapeutic targets

1. Childhood is a very sensitive and critical period for cognitive development. 2. High phenylalanine levels affect the brain and therefore its cognitive

development.

3. COgnition, BEhaviour and SOcial functioning are intertwined.

4. Data of this thesis suggest that an upper target Phe limit of 240 µmol/L in childhood results in even better executive functioning than the now recommended treatment target of 360 µmol/L (this thesis).

5. Childhood phenylalanine levels have the strongest effect on COBESO outcomes in adult life (this thesis).

6. In older patients with Phenylketonuria, the BESO part of the profile should be more emphasized as it is more affected and becomes more important than the CO part (this thesis).

7. Relaxing treatment/diet from adolescence onwards is not (always) favourable (this thesis).

8. Tetrahydrobiopterin (BH4) may have a positive effect on the cognitive

outcome of patients with PKU (this thesis).

9. The more I learn, the more I realize how much I don’t know (Albert Einstein). 10. Challenges are what makes life interesting and overcoming them is what

makes life meaningful (Joshua J. Marine). 11. Strive for progress, not perfection (Anonymous).

12. Life is not about waiting for the storm to pass. It’s about learning to dance in the rain (Vivian Greene).

Rianne Jahja 27 juni 2017

Referenties

GERELATEERDE DOCUMENTEN

Brain white matter integrity mediates the relationship between phenylalanine control and executive abilities in children with phenylketonuria.. What are the links between theory

examining more complex executive or COgnitive functions, BEhavioural problems, and SOcial functioning (COBESO) in early and continuously treated PKU patients in relation to

First, 6- to 15-year-old patients with PKU with mean Phe levels <240 µmol/L since birth outperformed those with higher mean Phe levels and outperformed those with mean lifetime

The exceptions were IQ, where patients with lifetime Phe ≥360 µmol/L had lower IQ scores than both controls and patients with Phe <360 µmol/L; one working memory task,

Cognitive and mental health problems in individuals with the inherited metabolic disorder Phenylketonuria (PKU) have often been associated with (history of)

controls (mean age 19.6 ± 8.7 years) were compared on performance of computerized and paper-and-pencil tasks measuring social-cognitive abilities and on parent- and

Therefore, in the current study we compared the BRIEF-A questionnaire with neurocognitive outcome as measured by the Amsterdam Neuropsychological Tasks (ANT; De Sonneville, 2014),

Overall, the most frequently observed finding was that patients with high Phe concentrations in childhood had poorer cognitive and behavioural outcomes (Chapter